title: [Trends in the hormonal therapy of thyroid cancer].
abstract: The highly differentiated thyroid cancers account for 0.70% of malignancies. Their management is primarily hormonal, in addition to the percutaneous irradiation and application of iodine isotope. This method is not aimed at the inhibition of the potential artificial hypothyreosis but mainly at the prevention of the tumour development or tumorous dissemination. The authors, in case of their 28 patients with the above diagnosis, tried to clarify if the TRH-tolerance TSH-level determination promotes the optimal patient management, the ideal hormone substitution lasting for several years. Their results suggest that the drugs containing L-thyroxin prove to be most effective in the clinical practice. Their optimal dose is 2.8-3.0 micrograms/kg. The study of the TRH-sensitized TSH-level does not primarily facilitate the ideal hormone substitution but may decrease the "unnecessary" amount of thyroid hormone-containing drugs. In view of the fact that the hormonal treatment may last even several decades for a patient, the authors considering economic points as well, do not reject the TRH-tolerance TSH-study. In their opinion the more favourable solution may be provided by the wide-scale application of the IRMA-TSH.
authors.forename: J
authors.initials: J
authors.lastname: Szántó
authors.forename: B
authors.initials: B
authors.lastname: Vincze
authors.forename: I
authors.initials: I
authors.lastname: Kazatsay
mesh_terms: D006801:Humans; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones / Q000008:administration & dosage*; D013964:Thyroid Neoplasms / Q000628:therapy*; D013972:Thyrotropin / Q000008:administration & dosage / Q000097:blood; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000097:blood
chemical_list: D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin
vernacular_title: Szempontok a pajzsmirigyrák hormonális kezelésében.